Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte T Huber

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|June 27, 2009
Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescenceDeanna A Mele, Pradeep Bista, Diana Velez Baez, et al.
Infection and Immunity|October 22, 2005
Aggravated Lyme carditis in CD11a-/- and CD11c-/- miceMireia Guerau-de-Arellano, Joseph Alroy, Daniel Bullard, et al.
Molecular Immunology|June 17, 2008
Lymphocyte quiescence factor Dpp2 is transcriptionally activated by KLF2 and TOB1Pradeep Bista, Deanna A Mele, Diana Velez Baez, et al.
Advances in Virology|February 8, 2012
Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence ImmunoassaysBrendan Oakes, Xiaoxing Qiu, Susan Levine, et al.
International Immunology|January 18, 2006
The MHC class I-related FcRn ameliorates murine Lyme arthritisHelena Crowley, Joseph Alroy, Thomas J Sproule, et al.
Molecular Immunology|May 17, 2003
Phosphorylation of the pro-apoptotic protein Bim in lymphocytes is associated with protection from apoptosisRobert J Seward, Priska D von Haller, Ruedi Aebersold, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2004
An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitopeTheresa A Willett, Abbie L Meyer, Eric L Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cellsFrancis C Hsiao, Miao Lin, Albert Tai, et al.
Current Molecular Medicine|October 7, 2006
Molecular pathogenesis of chronic lymphocytic leukemiaAlexey V Danilov, Olga V Danilova, Andreas K Klein, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitorOlga Danilova, Bei Li, A Katrin Szardenings, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|June 27, 2009
Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescenceDeanna A Mele, Pradeep Bista, Diana Velez Baez, et al.
Infection and Immunity|October 22, 2005
Aggravated Lyme carditis in CD11a-/- and CD11c-/- miceMireia Guerau-de-Arellano, Joseph Alroy, Daniel Bullard, et al.
Molecular Immunology|June 17, 2008
Lymphocyte quiescence factor Dpp2 is transcriptionally activated by KLF2 and TOB1Pradeep Bista, Deanna A Mele, Diana Velez Baez, et al.
Advances in Virology|February 8, 2012
Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence ImmunoassaysBrendan Oakes, Xiaoxing Qiu, Susan Levine, et al.
International Immunology|January 18, 2006
The MHC class I-related FcRn ameliorates murine Lyme arthritisHelena Crowley, Joseph Alroy, Thomas J Sproule, et al.
Molecular Immunology|May 17, 2003
Phosphorylation of the pro-apoptotic protein Bim in lymphocytes is associated with protection from apoptosisRobert J Seward, Priska D von Haller, Ruedi Aebersold, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2004
An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitopeTheresa A Willett, Abbie L Meyer, Eric L Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cellsFrancis C Hsiao, Miao Lin, Albert Tai, et al.
Current Molecular Medicine|October 7, 2006
Molecular pathogenesis of chronic lymphocytic leukemiaAlexey V Danilov, Olga V Danilova, Andreas K Klein, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitorOlga Danilova, Bei Li, A Katrin Szardenings, et al.
Pageof 5